BCAL Diagnostics Limited (ASX:BDX)
Australia · Delayed Price · Currency is AUD 0.0690
+0.0040 (6.15%)
Jul 16, 2025, 3:39 PM AEST
BCAL Diagnostics Market Cap
BCAL Diagnostics has a market cap or net worth of 25.25 million as of July 16, 2025. Its market cap has decreased by -26.96% in one year.
Market Cap
25.25M
Enterprise Value
19.54M
Revenue
2.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since July 21, 2021, BCAL Diagnostics's market cap has decreased from 51.72M to 25.25M, a decrease of -51.17%. That is a compound annual growth rate of -16.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 23.79M | -32.99% |
| Dec 31, 2024 | 35.50M | 42.50% |
| Dec 29, 2023 | 24.91M | 96.37% |
| Dec 29, 2022 | 12.69M | -50.95% |
| Dec 29, 2021 | 25.87M | -49.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 121.37B |
| Pro Medicus | 33.92B |
| Cochlear | 19.67B |
| Sonic Healthcare | 13.48B |
| Ramsay Health Care | 8.81B |
| Telix Pharmaceuticals | 8.06B |
| Ansell | 4.35B |
| Regis Healthcare | 2.21B |